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Identity 
Note: Only two cases, one with features identical to a 
case of t(18;21)(q21;q22), and a case of 
t(19;21)(q13.4;q22). 
Clinics and pathology 
Disease 
Acute non lymphocytic leukemia (ANLL) secondary to 
toxic exposure. 
Etiology 
ANLL occurred about 50 years after radiation exposure 
from nuclear explosion in one case, 5 years after 
treatment with antitopoisomerase II for lung cancer in 
the other case. 
Evolution 
Complete remission in the two patients; relapse in the 
one documented case. 
Prognosis 
Unknown. 
Genes involved and proteins 
Note 





Transcription is from telomere to centromere. 
Protein 
Contains a Runt domain and, in the C-term, a 
transactivation domain; forms heterodimers; widely 
expressed; nuclear localisation; transcription factor 
(activator) for various hematopoietic-specific genes. 
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